Developing antisense oligonucleotides for a TECPR2 mutation-induced, ultra-rare neurological disorder using patient-derived cellular models.
Mol Ther Nucleic Acids
; 29: 189-203, 2022 Sep 13.
Article
in En
| MEDLINE
| ID: mdl-35860385
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mol Ther Nucleic Acids
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United States